Pityriasis Rosea: Management When Acyclovir Has Not Resolved Symptoms or Skin Lesions
A structured next-line protocol applies when initial antiviral treatment for pityriasis rosea has not produced the expected improvement in symptoms or cleared skin lesions. The following outlines the failure condition that triggers this step and gives a partial overview of the approach.
First-line treatment with acyclovir (oral) aims to achieve improvement in symptoms and resolution of skin lesions. When these goals are not reached, further clinical management is indicated.
The next-line protocol for pityriasis rosea centres on a course of ultraviolet phototherapy. The specific type, session schedule, and duration are set out in the full structured regimen.
Improvement in severity and symptoms, and reduction of pruritus.
- Ultraviolet phototherapy can also be considered for severe cases.
- Two small studies found improvements in severity and symptoms in patients with pityriasis rosea who received ultraviolet B phototherapy multiple times per week for up to four weeks.
- Another study of 15 patients with extensive disease used low-dose ultraviolet A phototherapy two or three times per week until resolution or no further improvement of the rash.
- Pruritus was reduced in 12 of 15 patients.